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ABSTRACT 
1,1-Dimethylbiguanide is a hypoglycemic agent used in the treatment of non-insulin dependent Diabetes mellitus. It is a BCS Class –III drug 
having poor permeability. Plasma half life ranges from 1.5-3 hrs & oral bioavailability is 50-60%. Hence require frequent oral administration for 
adequate treatment of Diabetes in order to extend the gastric retention time oral sustained dosage form was developed in the form of 
microspheres using polymers (sodium CMC, HPMC K 100 M). The results presented that drug dissolution rate and drug entrapment increases 
while decreasing the polymer amount. All the formulations are evaluated for dissolution, entrapment efficiency, percentage buoyancy and 1,1-
Dimethylbiguanide Microspheres of formulations, F-4 was found to be optimized formulation based on in-vitro release pattern and percentage 
buoyancy entrapment efficiency. 
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INTRODUCTION 
Oral delivery of drugs [1] is the most preferable route of drug 
delivery due to ease of administration, patient compliance 
and flexibility in formulation etc. various attempts have been 
made to prolong the retention time of the dosage form in the 
stomach. The present study involved, preparation of 1,1-
Dimethylbiguanide floating microspheres  to improve the 
bioavailability by increasing residence time in stomach. 
Metformin is an anti- hyperglycemic agent which improves 
glucose tolerance in patients with type-2 diabetes. Its 
pharmacologic mechanisms of action are different from 
other classes of oral anti- hyperglycemic agents. Metformin 
decreases hepatic glucose production, decreases intestinal 
absorption of glucose and improves insulin sensitivity by 
increasing peripheral glucose uptake and utilization. 1,1-
Dimethylbiguanide quite frequently causes gastrointestinal 
problems such as nausea, stomach pain, diarrhea. It has 
short half life (4-6 hrs) and is absorbed from upper intestine 
with in 6 hrs. So repeated administration required is to 
maintain effective plasma concentration. So our objective is 
to prepare a sustained release floating microspheres. Thus, 
the development of floating drug delivery systems would 
clearly be advantageous. Dosage forms that are retained in 
the stomach would increase the absorption, improve drug 
efficiency, and decrease dose requirements. Thus an attempt 
was made in this investigation to use HPMC K100M, sodium 
CMC polymers to prepare 1,1-Dimethylbiguanide floating 
Microspheres. 
Floating microsphere drug delivery system 
In floating types the bulk density is less than the gastric fluid 
and so remains buoyant in stomach without affecting gastric 
emptying rate. The drug is released slowly at the desired 
rate, if the system is floating on gastric content, increases 
gastric residence and fluctuation in plasma concentration. It 
also reduces chances of striking and dose dumping and 
produce prolonged therapeutic effect. 
MATERIALS AND METHODS 
1,1-Dimethylbiguanide was purchased from Yarrow chem. 
Products Mumbai, India, Hydroxyl proply methyl cellulose 
was purchased from K100M Ozone International Mumbai. 
Sodium Carboxy methyl cellulose was purchased from Ozone 
International Mumbai, Sodium bicarbonate and Calcium 
chloride was purchased from S.D. Fine chemicals, Ltd, 
Mumbai. Sodium alginate was purchased from Loba Chemie 
Pvt. Ltd. Mumbai. 
The FT-IR spectra of pure 1,1-Dimethylbiguanide and 
microspheres loaded with 1,1-Dimethylbiguanide were 
recorded to check drug polymer interaction and stability of 
drug. 
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Process of Formulation 
Floating alginate microspheres of 1,1-Dimethylbiguanide 
were prepared by ionotropic gelation technique using 
different proportion of polymers as shown in table No. 3. A 
3% w/v solution of sodium alginate solution was added to 
weighed amount of Na CMC dissolved in required quantity of 
ethanol. Weighed quantity of drug and HPMC K100 M was 
triturated to form fine powder, and then added to above 
solution. Sodium carbonate, gas forming agent was added to 
this mixture. 
Agitation 
The above mixture was taken into beaker for which an 
agitator and the agitator is allowed to rotate at fixed speed. 
Now the above solution of drug and polymer was dropped 
into 100 ml of gently agitated calcium chloride (3 % w/v) 
solution using a 26 G syringe needle to obtain 
microspheres. The solution containing Microspheres was 
stirred slowly using magnetic bead for about 10 min. the 
Microspheres were further allowed to remain in the same 
solution for 20 min to improve mechanical strength. 
Filteration 
The formed Microspheres were filtered, by using whatmann 
filter paper and washed with distilled water, air-dried at 
room temperature and stored in desiccators. 
Drying 
After filtration microspheres were dried in the hot air oven 
at the temperature 35-450C for the period of 1- 2 hrs. Then 
the microspheres kept in desiccators. 
Buoyancy Nature 
Alginate microspheres were formed as alginate undergoes 
ionotropic gelation by calcium  ions and carbon dioxide 
develops from the reaction of bicarbonate salt with acid 
which permeates through alginate matrix leaving gas 
bubbles or pores within microspheres, providing the 
buoyancy. 
RESULTS AND DISCUSSIONS 
Calibration curve of 1,1-Dimethylbiguanide by UV 
spectral analysis 
 
Fig No.5: Calibration curve for 1,1-Dimethylbiguanide in 
pH 1.2HCl buffer 
Accurately weighed amount of 1,1-Dimethylbiguanide 
(100mg) was dissolved in pH 1.2 buffer to form a clear 
solution and it was made up to the volume in 100 ml 
volumetric flask with pH 1.2 HCL buffer. From this solution 
1ml was transferred into 10 ml of volumetric flask and it 
was made upto volume with HCL buffer pH 1.2. The 
resulting solution (100 µg/ml). From this 1ml, 2ml, 3ml, 
4ml, 5ml was pippeted out and diluted to 10 ml with pH 1.2 
HCL to obtain 10ug/ml, 20ug/ml, 30ug/ml, 40ug/ml, 
50ug/ml and scanned over the range 233 nm against pH 1.2 
HCl buffer as blank UV spectrophotometer. 
Preformulation Studies 
Drug Excipient compatibility studies 
The compatibility of drug and formulation components is 
important prerequisite before formulation. It is therefore 
necessary to confirm that the drug does not react with the 
polymers and excipients under experimental conditions and 
affect the shelf life of product or any other unwanted effects 
on the formulation. 
Fourier transforms infra-red spectroscopy (FT-IR) 
analysis 
The compatibility study between the drug and the polymer 
was done by I.R studies. No major peak shift was observed in 
the I.R graphs in major functional groups. Based on the 
compatibility studies obtained by I.R studies, the polymer 
HPMC K100 M, sodium CMC were taken for the optimization 
of the formulation, which is compatible with the drug. The 
FT-IR spectra of pure 1,1-Dimethylbiguanide and 
microspheres loaded with 1,1-Dimethylbiguanide were 
recorded to check drug polymer interaction and stability of 
drug. 
 
Fig No. 1: FTIR graph for the pure drug 1,1-
Dimethylbiguanide 
 
Fig No. 2: FTIR graph of polymer (Na CMC)
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 Fig No: 3 FTIR graph of Drug and Drug and Polymer 
(HPMC K 100 M)  
Evaluation of prepared microspheres External 
morphological study Particle size 
External morphology of microspheres was determined using 
scanning electron microscopy (SEM). Samples were diluted 
with ultra-purified water to obtain a suitable concentration. 
Then the samples were spread on a sample holder and dried 
using vacuum and examined by a scanning electron 
microscopy. 
 
Fig No: 4 SEM of formulated Microspheres 
Percentage yield 
The prepared microspheres of all batches were accurately 
weighed. The measured weight of prepared microspheres 
was divided by total amount of all the excipient and drug 
used in preparation of the microspheres, which give the total 
percentage yield of floating microspheres. 
 
It was calculated by using following equation. 
                              Actual weight of product 
PY(%) = 
Total weight of excipient and drug
 
Table No1: Percentage yield of different formulations 
Formulations Total weight 
taken (mg) 
Total weight of 
microspheres (mg) 
Percentage 
yield (%) 
F-1 1100 750 68.1 
F-2 1050 700 66.6 
F-3 1050 750 71.4 
F-4 1000 720 72 
 
 
Inference 
From the above table the percentage yield of prepared 
Microspheres was found to be more for the formulation F- 4 
(72%). 
Drug content/entrapment efficiency 
100 mg of prepared floating microspheres are dispersed in 
100ml of pH1.2 HCL buffer. This dispersion kept a side 
overnight. Then samples were taken from this solution and 
absorbance values measured by UV spectrophotometer at 
233 nm. By using drug content values we can measure the 
entrapment efficiency. 
Estimated percent drug content 
Microencapsulation efficiency =                                                             ×100 
  Theoretical percent drug content 
 
In calculation of entrapment efficiency first measure amount 
of drug loaded in the total microspheres. For this U.V visible 
spectrophotometer is used for the analysis of drug.
 
Table No. 2: Entrapment efficiency of the different formulations 
Formulations Observed drug 
(mg) 
Total amount  
taken (mg) 
Entrapment 
efficiency(%) 
F-1 45 100 67.5 
F-2 47 100 65.8 
F-3 46 100 69 
F-4 49 100 70.56 
 
 
Inference 
From the above table Entrapment efficiency was found to be 
more for the formulation F – 4 i.e. (70.56%). 
Percentage buoyancy 
Microspheres (0.3g) were spread over the surface of a USP 
XXIV dissolution apparatus (type 
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II) filed with 900 ml 0.1 N HCL. The medium was agitated 
with paddle rotating at 100 rpm for 12 hrs. The floating and 
the settled portion of microspheres were recovered 
separately. The Microspheres were dried and weighed. 
Buoyancy percentage was calculated as the ratio of the 
microspheres that remained floating and the total mass of 
the Microspheres. 
                              Weight of floating microspheres at time t 
% Floating microspheres =  × 100 
                                   Initial weight of microspheres 
Table No. 3: Buoyancy percentage of different 
formulations 
Formulation code Percentage buoyancy 
F-1 81.66 
F-2 83.33 
F-3 85.1 
F-4 86 
 
 
Inference 
From the above table the percentage buoyancy was found to 
be more for the formulation F -4. 
IN VITRO DISSOLUTION DATA 
Dissolution test 
The dissolution profiles of floating microspheres of 1,1-
Dimethylbiguanide were investigated with a dissolution 
apparatus (LAB INDIA DS-8000), according to type II paddle 
method, with the rotation speed of paddle was set on 100 
and the bath temperature was kept at 37.0 ± 0.5oc. 
Equivalent 100 percent of drug preparation was filled into 
the empty capsule. The capsule was put into the vessel 
containing 900 ml of pH 1.2 HCl. To avoid the float of capsule 
sinkers were used. At specific intervals, 1 ml of aliquot of 
dissolution medium was sampled, filtered the sample by the 
U.V and visible spectrophotometer. Absorbance of the 
sample solution compared with the standard solution having 
a known concentration of 1,1-Dimethylbiguanide was drawn 
at 233 nm. 
 
Table No.16: Comparative dissolution profile for formulation F1 – F4 
S.NO F-1 % CDR F-2 % CDR F-3 % CDR F-4 % CDR 
1 0 0 0 0 
2 11.08 12.1 19.9 9.5 
3 18 21.6 21.6 26.1 
4 27 26.1 31.5 29.7 
5 31.5 37.8 39.6 41.4 
6 37.8 45 46.8 47.7 
7 46.8 50.4 54 57.6 
8 52.2 59.4 71.1 67.5 
9 56.7 69.3 75.6 81 
10 67.5 71.1 79.2 82.8 
11 73.8 74.7 82.8 84.6 
12 75.6 80.1 85.5 87.3 
13 81 81 88.2 90 
 
 
Fig No. 20: Comparative dissolution profile for formulation F1-F4. 
Inference 
From the above fig the dissolution profile for the formulation F-4 was found to be have the more cumulative % drug release. 
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DISSOLUTION – APPLICATION OF KINETICS OF F-4 
Table NO. 17: Application of kinetics for dissolution profile of formulation F-4. 
S.NO TIME % CDR Log % CDR Log % drug 
unreleased 
Square root 
time 
Log time 
1 0.5 9.5 0.9777 1.9566 0.7071 -0.301 
2 1 26.1 1.4166 1.8686 1 0 
3 2 29.7 1.4727 1.8469 1.414 0.3010 
4 3 41.4 1.6170 1.7678 1.732 0.4771 
5 4 47.7 1.6785 1.7185 2 0.602 
6 5 57.6 1.7604 1.6273 2.236 0.6989 
7 6 67.5 1.8293 1.5118 2.449 0.778 
8 7 81.0 1.9084 1.2787 2.645 0.845 
9 8 82.8 1.9180 1.2355 2.828 0.903 
10 9 84.6 1.9273 1.1875 3 0.954 
11 10 87.3 1.9410 1.1038 3.167 1 
12 11 90 1.9542 1 3.316 1.041 
 
ZERO ORDER PLOT 
 
Fig No. 21: Zero order plot for optimized formulation F-4 
FIRST ORDER PLOT 
 
Fig No. 22: First Order Plot for optimized formulation F-
4 
Inference 
From the above graphs the R2 value is (0.977) and for zero 
order plot R2 value is (0.957) which indicating that the order 
of release was first order. 
 
 
 
 
 
HIGUCHI’S PLOT 
 
Fig No. 23: Higuchi’s plot for optimized formulation F-4 
KORSEMEYER- PEPPAS PLOT 
 
Fig No. 24: Korsemeyer -Peppas plot for optimized 
formulation F-4 
Inference 
As per the above plot Fig No. 17 and Fig No. 18. The R2 value 
for Higuchi (0.974) and for Korsemeyer - Peppas plot 
(0.964), showing that the mechanism of drug release from 
the formulation was found to be Diffusion controlled release. 
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Stability studies 
The accelerated stability study for the formulation at 40 ± 
20C and 75 ± 5% RH was conducted for the 3 months, which 
includes the testing of parameters like identification of 
physical characters, identified by IR studies, dissolution 
profile and assay throughout period. 
The stability studies on optimized formulation of 1,1-
Dimethylbiguanide floating Microspheres were conducted 
according to the ICH guidelines. 
CONCLUSION 
The present study involved, preparation of 1,1-
Dimethylbiguanide floating microspheres  to improve the 
bioavailability by increasing residence time in stomach. Thus 
an attempt was made in this investigation to use HPMC 
K100M, sodium CMC polymers to prepare 1,1-
Dimethylbiguanide floating Microspheres. 
From the study, it was concluded that spherical and free 
flowing Microspheres of Metformin HCL could be 
successfully prepared by Ionotropic gelation technique with 
high entrapment efficiency and prolonged release 
characteristics. 
It was concluded that 
 Compatibility studies revealed no interactions between 
the drug and polymers used. 
 Formulated Microspheres gave satisfactory result for 
various physic- chemical evaluations like physical 
appearance, surface morphology, entrapment 
efficiency, percentage drug loading, percentage 
buoyancy and In-vitro drug release. 
 The prepared beads showed required drug release in 
about 12 hours as aimed for. 
 From the research, it can be concluded that 1,1-
Dimethylbiguanide can be formulated as Microspheres 
for the desired use in treatment of Diabetes Mellitus. 
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